GB201610497D0 - Compound - Google Patents
CompoundInfo
- Publication number
- GB201610497D0 GB201610497D0 GBGB1610497.8A GB201610497A GB201610497D0 GB 201610497 D0 GB201610497 D0 GB 201610497D0 GB 201610497 A GB201610497 A GB 201610497A GB 201610497 D0 GB201610497 D0 GB 201610497D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1610497.8A GB201610497D0 (en) | 2016-06-16 | 2016-06-16 | Compound |
| PCT/GB2017/051767 WO2017216579A1 (en) | 2016-06-16 | 2017-06-16 | Autophagy inducer compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1610497.8A GB201610497D0 (en) | 2016-06-16 | 2016-06-16 | Compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201610497D0 true GB201610497D0 (en) | 2016-08-03 |
Family
ID=56895082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1610497.8A Ceased GB201610497D0 (en) | 2016-06-16 | 2016-06-16 | Compound |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201610497D0 (en) |
| WO (1) | WO2017216579A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4183449A1 (en) | 2021-11-17 | 2023-05-24 | Samsara Therapeutics Inc. | Autophagy inducing compounds and uses thereof |
| EP4653432A1 (en) | 2024-05-24 | 2025-11-26 | Samsara Therapeutics Inc. | Autophagy inducing compounds and uses thereof in the prevention or therapy of diseases |
| EP4653430A1 (en) | 2024-05-24 | 2025-11-26 | Samsara Therapeutics Inc. | Autophagy inducing compounds and uses thereof, in particular for the prevention or treatment of diseases of the cns |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101224207A (en) * | 2007-10-12 | 2008-07-23 | 中国科学院上海有机化学研究所 | Drugs capable of inducing autophagy to treat diseases caused by misfolded protein aggregation and screening methods thereof |
-
2016
- 2016-06-16 GB GBGB1610497.8A patent/GB201610497D0/en not_active Ceased
-
2017
- 2017-06-16 WO PCT/GB2017/051767 patent/WO2017216579A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017216579A1 (en) | 2017-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201602934D0 (en) | Compounds | |
| GB201620119D0 (en) | Compounds | |
| GB201619694D0 (en) | Compounds | |
| GB201604020D0 (en) | Compounds | |
| GB201604027D0 (en) | Compounds | |
| GB201610854D0 (en) | Compounds | |
| GB201608777D0 (en) | Compounds | |
| GB201613946D0 (en) | Compounds | |
| IL258952B (en) | Pyranodipyridine compound | |
| GB201604022D0 (en) | Compounds | |
| GB201521524D0 (en) | Compound | |
| GB201604030D0 (en) | Compounds | |
| GB201617103D0 (en) | Compound | |
| GB201621520D0 (en) | Compounds | |
| GB201610497D0 (en) | Compound | |
| GB201713217D0 (en) | Compounds | |
| GB201622362D0 (en) | Compounds | |
| GB201612652D0 (en) | Novel compound | |
| GB201604029D0 (en) | Compounds | |
| GB201622365D0 (en) | Compounds | |
| GB201604031D0 (en) | Compounds | |
| GB201518950D0 (en) | Compound | |
| ZA201801098B (en) | Tetrahydrooxepinopyridine compound | |
| GB201619526D0 (en) | Compound | |
| GB201619531D0 (en) | Compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |